Fluicell CEO Newsletter 02, 2023

Changing research at the core has been a driving force for us at Fluicell from the start. Through our tissue engineering technology, we have the opportunity to take on a leading role in transforming how we treat diseases.

Read Victoire Viannay’s thoughts on Fluicell’s path to success in the new edition of our CEO newsletter, which you can access in both English and Swedish. You can also read the newsletter directly on our website.